MoneyWorks4Me

Dr. Lal PathLabs informs about analyst meeting

23 Jun 2017 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr. Lal PathLabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting.

The above information is a part of company’s filings submitted to BSE.

Peers